Cargando…
Protocol for an individual patient data meta‐analysis on blood pressure targets after cardiac arrest
BACKGROUND: Hypotension is common after cardiac arrest (CA), and current guidelines recommend using vasopressors to target mean arterial blood pressure (MAP) higher than 65 mmHg. Pilot trials have compared higher and lower MAP targets. We will review the evidence on whether higher MAP improves outco...
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9543739/ https://www.ncbi.nlm.nih.gov/pubmed/35616252 http://dx.doi.org/10.1111/aas.14090 |
_version_ | 1784804445233610752 |
---|---|
author | Skrifvars, Markus B. Ameloot, Koen Grand, Johannes Reinikainen, Matti Hästbacka, Johanna Niemelä, Ville Hassager, Christian Kjaergaard, Jesper Åneman, Anders Tiainen, Marjaana Nielsen, Niklas Ullen, Susann Dankiewicz, Josef Olsen, Markus Harboe Jørgensen, Caroline Kamp Saxena, Manoj Jakobsen, Janus C. |
author_facet | Skrifvars, Markus B. Ameloot, Koen Grand, Johannes Reinikainen, Matti Hästbacka, Johanna Niemelä, Ville Hassager, Christian Kjaergaard, Jesper Åneman, Anders Tiainen, Marjaana Nielsen, Niklas Ullen, Susann Dankiewicz, Josef Olsen, Markus Harboe Jørgensen, Caroline Kamp Saxena, Manoj Jakobsen, Janus C. |
author_sort | Skrifvars, Markus B. |
collection | PubMed |
description | BACKGROUND: Hypotension is common after cardiac arrest (CA), and current guidelines recommend using vasopressors to target mean arterial blood pressure (MAP) higher than 65 mmHg. Pilot trials have compared higher and lower MAP targets. We will review the evidence on whether higher MAP improves outcome after cardiac arrest. METHODS: This systematic review and meta‐analysis will be conducted based on a systematic search of relevant major medical databases from their inception onwards, including MEDLINE, Embase and the Cochrane Central Register of Controlled Trials (CENTRAL), as well as clinical trial registries. We will identify randomised controlled trials published in the English language that compare targeting a MAP higher than 65–70 mmHg in CA patients using vasopressors, inotropes and intravenous fluids. The data extraction will be performed separately by two authors (a third author will be involved in case of disagreement), followed by a bias assessment with the Cochrane Risk of Bias tool using an eight‐step procedure for assessing if thresholds for clinical significance are crossed. The outcomes will be all‐cause mortality, functional long‐term outcomes and serious adverse events. We will contact the authors of the identified trials to request individual anonymised patient data to enable individual patient data meta‐analysis, aggregate data meta‐analyses, trial sequential analyses and multivariable regression, controlling for baseline characteristics. The certainty of the evidence will be assessed by the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) system. We will register this systematic review with Prospero and aim to redo it when larger trials are published in the near future. CONCLUSIONS: This protocol defines the performance of a systematic review on whether a higher MAP after cardiac arrest improves patient outcome. Repeating this systematic review including more data likely will allow for more certainty regarding the effect of the intervention and possible sub‐groups differences. |
format | Online Article Text |
id | pubmed-9543739 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-95437392022-10-14 Protocol for an individual patient data meta‐analysis on blood pressure targets after cardiac arrest Skrifvars, Markus B. Ameloot, Koen Grand, Johannes Reinikainen, Matti Hästbacka, Johanna Niemelä, Ville Hassager, Christian Kjaergaard, Jesper Åneman, Anders Tiainen, Marjaana Nielsen, Niklas Ullen, Susann Dankiewicz, Josef Olsen, Markus Harboe Jørgensen, Caroline Kamp Saxena, Manoj Jakobsen, Janus C. Acta Anaesthesiol Scand Special Articles BACKGROUND: Hypotension is common after cardiac arrest (CA), and current guidelines recommend using vasopressors to target mean arterial blood pressure (MAP) higher than 65 mmHg. Pilot trials have compared higher and lower MAP targets. We will review the evidence on whether higher MAP improves outcome after cardiac arrest. METHODS: This systematic review and meta‐analysis will be conducted based on a systematic search of relevant major medical databases from their inception onwards, including MEDLINE, Embase and the Cochrane Central Register of Controlled Trials (CENTRAL), as well as clinical trial registries. We will identify randomised controlled trials published in the English language that compare targeting a MAP higher than 65–70 mmHg in CA patients using vasopressors, inotropes and intravenous fluids. The data extraction will be performed separately by two authors (a third author will be involved in case of disagreement), followed by a bias assessment with the Cochrane Risk of Bias tool using an eight‐step procedure for assessing if thresholds for clinical significance are crossed. The outcomes will be all‐cause mortality, functional long‐term outcomes and serious adverse events. We will contact the authors of the identified trials to request individual anonymised patient data to enable individual patient data meta‐analysis, aggregate data meta‐analyses, trial sequential analyses and multivariable regression, controlling for baseline characteristics. The certainty of the evidence will be assessed by the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) system. We will register this systematic review with Prospero and aim to redo it when larger trials are published in the near future. CONCLUSIONS: This protocol defines the performance of a systematic review on whether a higher MAP after cardiac arrest improves patient outcome. Repeating this systematic review including more data likely will allow for more certainty regarding the effect of the intervention and possible sub‐groups differences. John Wiley and Sons Inc. 2022-06-09 2022-08 /pmc/articles/PMC9543739/ /pubmed/35616252 http://dx.doi.org/10.1111/aas.14090 Text en © 2022 The Authors. Acta Anaesthesiologica Scandinavica published by John Wiley & Sons Ltd on behalf of Acta Anaesthesiologica Scandinavica Foundation. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Special Articles Skrifvars, Markus B. Ameloot, Koen Grand, Johannes Reinikainen, Matti Hästbacka, Johanna Niemelä, Ville Hassager, Christian Kjaergaard, Jesper Åneman, Anders Tiainen, Marjaana Nielsen, Niklas Ullen, Susann Dankiewicz, Josef Olsen, Markus Harboe Jørgensen, Caroline Kamp Saxena, Manoj Jakobsen, Janus C. Protocol for an individual patient data meta‐analysis on blood pressure targets after cardiac arrest |
title | Protocol for an individual patient data meta‐analysis on blood pressure targets after cardiac arrest |
title_full | Protocol for an individual patient data meta‐analysis on blood pressure targets after cardiac arrest |
title_fullStr | Protocol for an individual patient data meta‐analysis on blood pressure targets after cardiac arrest |
title_full_unstemmed | Protocol for an individual patient data meta‐analysis on blood pressure targets after cardiac arrest |
title_short | Protocol for an individual patient data meta‐analysis on blood pressure targets after cardiac arrest |
title_sort | protocol for an individual patient data meta‐analysis on blood pressure targets after cardiac arrest |
topic | Special Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9543739/ https://www.ncbi.nlm.nih.gov/pubmed/35616252 http://dx.doi.org/10.1111/aas.14090 |
work_keys_str_mv | AT skrifvarsmarkusb protocolforanindividualpatientdatametaanalysisonbloodpressuretargetsaftercardiacarrest AT amelootkoen protocolforanindividualpatientdatametaanalysisonbloodpressuretargetsaftercardiacarrest AT grandjohannes protocolforanindividualpatientdatametaanalysisonbloodpressuretargetsaftercardiacarrest AT reinikainenmatti protocolforanindividualpatientdatametaanalysisonbloodpressuretargetsaftercardiacarrest AT hastbackajohanna protocolforanindividualpatientdatametaanalysisonbloodpressuretargetsaftercardiacarrest AT niemelaville protocolforanindividualpatientdatametaanalysisonbloodpressuretargetsaftercardiacarrest AT hassagerchristian protocolforanindividualpatientdatametaanalysisonbloodpressuretargetsaftercardiacarrest AT kjaergaardjesper protocolforanindividualpatientdatametaanalysisonbloodpressuretargetsaftercardiacarrest AT anemananders protocolforanindividualpatientdatametaanalysisonbloodpressuretargetsaftercardiacarrest AT tiainenmarjaana protocolforanindividualpatientdatametaanalysisonbloodpressuretargetsaftercardiacarrest AT nielsenniklas protocolforanindividualpatientdatametaanalysisonbloodpressuretargetsaftercardiacarrest AT ullensusann protocolforanindividualpatientdatametaanalysisonbloodpressuretargetsaftercardiacarrest AT dankiewiczjosef protocolforanindividualpatientdatametaanalysisonbloodpressuretargetsaftercardiacarrest AT olsenmarkusharboe protocolforanindividualpatientdatametaanalysisonbloodpressuretargetsaftercardiacarrest AT jørgensencarolinekamp protocolforanindividualpatientdatametaanalysisonbloodpressuretargetsaftercardiacarrest AT saxenamanoj protocolforanindividualpatientdatametaanalysisonbloodpressuretargetsaftercardiacarrest AT jakobsenjanusc protocolforanindividualpatientdatametaanalysisonbloodpressuretargetsaftercardiacarrest |